Expand Document  |  Expand Chapter  |  Full TOC  |  Printable HTML version
Proceedings of the Tenth International Conference of Drug Regulatory Authorities (ICDRA) - Hong Kong, China, 24 - 27 June 2002
(2002; 166 pages) View the PDF document
Table of Contents
View the documentAbbreviations and acronyms used in this report
Open this folder and view contentsOpening ceremony
Open this folder and view contentsHerbal medicines
Open this folder and view contentsKeynote address
Open this folder and view contentsSafety of blood-derived products
Open this folder and view contentsAntimicrobial resistance - new initiatives
Open this folder and view contentsHarmonization I
Open this folder and view contentsHarmonization II
Open this folder and view contentsProtection of trial subjects in clinical trials
Open this folder and view contentsRegulating biotechnology products
Open this folder and view contentsRegulatory challenges: health sector reform and drug regulatory capacity
Open this folder and view contentsAccess to drugs and vaccines I
Open this folder and view contentsAccess to drugs and vaccines II
Open this folder and view contentsCounterfeit pharmaceutical products
Open this folder and view contentsHomoeopathy
Open this folder and view contentsSafety monitoring
Open this folder and view contentsE-Commerce
Open this folder and view contentsCurrent topics
Open this folder and view contentsRegulatory challenges of new technologies
View the documentList of participants
View the documentBack cover
 

Abbreviations and acronyms used in this report

ADR

adverse drug reaction

AIDS

acquired immunodeficiency syndrome

ARV

antiretroviral

ASEAN

Association of South-East Asian Nations

BSE

bovine spongiform encephalopathy

CAM

complementary and alternative medicine

CIOMS

Council for International Organizations of Medical Sciences

CJD

Creutzfeldt-Jakob disease

CPMP

Committee for Proprietary Medicinal Products

CPP

Certificate of a Pharmaceutical Product

CRO

contract research organization

DRA

drug regulatory authority

DT

diphtheria and tetanus (vaccine)

EMEA

European Agency for the Evaluation of Medicines

EU

European Union

GCC

Gulf Cooperation Council

GCP

Good Clinical Practices

GLP

Good Laboratory Practices

GMP

Good Manufacturing Practices

GSP

Good Supplies Practices

HAV

hepatitis A virus

HBV

hepatitis B virus

HCV

hepatitis C virus

HIV

human immunodeficiency virus

HTLV

human T-cell lymphotropic virus

ICDRA

International Conference of Drug Regulatory Authorities

ICH

International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use

MMR

measles, mumps, rubella (vaccine)

MOH

Ministry of Health

NAT

nucleic acid testing

OECD

Organisation for Economic Co-operation and Development

OIE

Office international des Epizooties

R&D

research and development

SPC

summary of product characteristics

TCM

traditional Chinese medicine

TRIPS

Trade-Related Intellectual Property Rights (Agreement)

TSE

transmissible spongiform encephalopathy

TT

tetanus toxoid

UMC

Uppsala Monitoring Centre

WHA

World Health Assembly

WHO

World Health Organization

 

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: August 29, 2014